Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

Lipoprotein Deficient Serum, bovine, BT-907 - LPDS - Bovine Serum, lipoprotein deficient - J65182 - Alfa Aesar

J65182 Lipoprotein Deficient Serum, bovine, BT-907

Codice CAS
Sinonimi
LPDS
Bovine Serum, lipoprotein deficient

Dimensioni Prezzo ($) Quantità Disponibilità
2x25ml 315,00
25ml Pricing available on request. Click Add to Quote Request button and specify size.
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

Lipoprotein Deficient Serum, bovine, BT-907

Proprietà chimiche

Modulo
Liquid

Applicazioni

Each lot is evaluated in culture with our LDLs to determine the degree of up regulation of LDL receptors. Lipoprotein Deficient Serum, bovine is used for blocking of interfering antibodies. It is evaluated in conjunction with low-density lipoprotein (LDL) to determine the degree of up regulation of low-density lipoprotein receptors.

The absence of lipoproteins allows for the undertaking of binding studies of lipoproteins to cells without the interference of the endogenous lipoproteins.

Note

Prepared from calf serum. Store frozen (-20° C). Stable for 6-12 months if frozen.

The sequential centrifugation used to produce this human lipoprotein deficient serum removes 99% of the circulating lipoproteins (chylomicrons, VLDL, IDL, LDL HDL) and their associated lipids. What remains in the LPDS is mainly fatty acids bound to proteins such as albumin.

This product is virtually lipoprotein free but not totally lipid free due to the presence of mainly the non-lipoprotein associated fatty acids. There may also be a very small of amount of sterols such as cholesterol bound to some proteins as well.

If there is a need for lipid free serum, then there are multiple protocols in the literature for the production of lipid free serum by the use of organic solvent extraction. Most of those protocols remove 97-99% of the cholesterol, triglycerides, and free fatty acids.

Letteratura

Salminen, A.; Åström, P.; Metso, J.; Soliymani, R.; Salo, T.; Jauhiainen, M.; Pussinen, P. J.; Sorsa, T. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity. FASEB J. 2015, 29 (4), 1435-1445.

Romagnuolo, R.; Scipione, C. A.; Boffa, M. B.; Marcovina, S. M.; Seidah, N. G.; Koschinsky, M. L. Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor. J. Biol. Chem. 2015, 290 (18), 11649-11662.

Altri riferimenti

Codice tariffe armonizzato
3002.19
TSCA
No

Raccomandato

  • J66153

    beta-Bag Cell Peptide
  • 42143

    Molybdenum plate, 4.76mm (0.188in) thick, 99.95% (metals basis)
  • A15260

    Indole-3-butyric acid, 98%
  • H66036

    2-[(Ethoxycarbonothioyl)thio]-2-methylpropionic acid, 95%
  • H58488

    Ethyl 2-(1-Fmoc-3-indolyl)thiazole-4-carboxylate, 97%

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio